Lang H, Sotiropoulos G C, Dömland M, Frühauf N R, Paul A, Hüsing J, Malagó M, Broelsch C E
Klinik für Allgemein- und Transplantationschirurgie, University Hospital Essen, Germany.
Br J Surg. 2005 Feb;92(2):198-202. doi: 10.1002/bjs.4763.
Hepatocellular carcinoma (HCC) arising in normal liver parenchyma is rare and the outcome after hepatectomy is not well documented.
Between June 1998 and September 2003, 33 patients without viral hepatitis underwent resection for HCC in a non-cirrhotic, non-fibrotic liver. Data were analysed with regard to operative details, pathological findings including completeness of resection, and outcome as measured by tumour recurrence and survival.
Twenty-three major hepatectomies and ten segmentectomies or bisegmentectomies were performed. After potentially curative resection, 19 of 29 patients were alive at a median follow-up of 25 months, with calculated 1- and 3-year survival rates of 87 and 50 per cent respectively. Survival was significantly better after resection of tumours without vascular invasion (3-year survival rate 89 versus 18 per cent; P = 0.024). Disseminated recurrence developed in nine of 29 patients, leading to death within 28 months of operation in all but one of the nine.
These data justify hepatic resection for HCC arising in non-cirrhotic, non-fibrotic liver without underlying viral hepatitis. Liver transplantation is rarely indicated because the outcome is good after resection of tumours without vascular infiltration, whereas vascular invasion is invariably associated with diffuse extrahepatic recurrence.
正常肝实质中发生的肝细胞癌(HCC)较为罕见,肝切除术后的结果尚无充分记录。
1998年6月至2003年9月期间,33例无病毒性肝炎的患者在非肝硬化、非纤维化肝脏中接受了HCC切除术。分析了手术细节、病理结果(包括切除完整性)以及以肿瘤复发和生存衡量的结果。
进行了23例大肝切除术和10例肝段切除术或双肝段切除术。在可能治愈性切除后,29例患者中有19例在中位随访25个月时存活,计算得出的1年和3年生存率分别为87%和50%。无血管侵犯的肿瘤切除术后生存率明显更高(3年生存率89%对18%;P = 0.024)。29例患者中有9例发生播散性复发,除1例患者外,其余9例均在术后28个月内死亡。
这些数据证明了对无潜在病毒性肝炎的非肝硬化、非纤维化肝脏中发生的HCC进行肝切除是合理的。肝移植很少被推荐,因为无血管浸润的肿瘤切除术后结果良好,而血管侵犯总是与弥漫性肝外复发相关。